Atlas Trials

Nanoscope Therapeutics Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nanoscope Therapeutics Inc.

RecordFirmDate
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT (NCT06805474)Nanoscope Therapeutics Inc.2025-01-28
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study (NCT06162585)Nanoscope Therapeutics Inc.2023-12-08
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection (NCT05921162)Nanoscope Therapeutics Inc.2023-07-14
Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT (NCT05820100)Nanoscope Therapeutics Inc.2023-04-25
Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease (NCT05417126)Nanoscope Therapeutics Inc.2022-07-05
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE] (NCT04945772)Nanoscope Therapeutics Inc.2021-07-13
Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis Pigmentosa (NCT04919473)Nanoscope Therapeutics Inc.2019-10-23

Track Nanoscope Therapeutics Inc. automatically

Every clearance here is in the API, with alerts when new ones post.